quinazolines has been researched along with Cafe-au-Lait Spots with Pulmonic Stenosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Balcı, Y; Çağlar Çıtak, E; Demir Gündoğan, B; Sağcan, F; Tuğ Bozdoğan, S; Tuncel Daloğlu, F | 1 |
Dilworth, JT; Hancock, CN; Mathieu, P; Mattingly, RR; Reiners, JJ; Tainsky, MA; Wojtkowiak, JW | 1 |
2 other study(ies) available for quinazolines and Cafe-au-Lait Spots with Pulmonic Stenosis
Article | Year |
---|---|
Vandetanib in a Child Affected by Neurofibromatosis Type 1 and Medullary Thyroid Carcinoma with Both
Topics: Adolescent; Antineoplastic Agents; Biomarkers, Tumor; Carcinoma, Neuroendocrine; Germ-Line Mutation; Homozygote; Humans; Male; Neurofibromatosis 1; Neurofibromin 1; Piperidines; Proto-Oncogene Proteins c-ret; Quinazolines; Thyroid Neoplasms; Treatment Outcome | 2021 |
Suppression of proliferation of two independent NF1 malignant peripheral nerve sheath tumor cell lines by the pan-ErbB inhibitor CI-1033.
Topics: Antineoplastic Agents; Cell Division; Cell Line, Tumor; ErbB Receptors; Gefitinib; Humans; Morpholines; Nerve Sheath Neoplasms; Neurofibromatosis 1; Protein-Tyrosine Kinases; Quinazolines; Receptor, ErbB-2 | 2008 |